Sign up to the UK Share Picking Game

Oxford Biomedica (OXB) Health Care Sector

Latest Quote Price

Price Change (%)

Trading Velocity

Activity Score

Momentum Score

Consensus Score


Latest Bid : Latest Ask :
High Today : Low Today :
This Years High : This Years Low :
Volume : MKT Cap :

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000


Oxford Biomedica Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

Latest Oxford Biomedica Tips

Type Tipster SectorScore Start date Performance
RBC Capital 2022-04-22 06:35:00 22/04/2022
Liberum Capital 2022-04-20 09:51:00 20/04/2022
RBC Capital 2022-03-24 17:46:00 24/03/2022
Alan Oscroft 2022-02-02 15:55:00 02/02/2022
RBC Capital 2022-02-01 06:11:00 01/02/2022

Oxford Biomedica Data Charts

Premium Charts

Latest Bid : Latest Ask :
High Today : Low Today :
This Years High : This Years Low :
Volume : MKT Cap :

Oxford Biomedica Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

Latest Oxford Biomedica Tips

Type Tipster SectorScore Start date Performance
RBC Capital 2022-04-22 06:35:00 22/04/2022
Liberum Capital 2022-04-20 09:51:00 20/04/2022
RBC Capital 2022-03-24 17:46:00 24/03/2022
Alan Oscroft 2022-02-02 15:55:00 02/02/2022
RBC Capital 2022-02-01 06:11:00 01/02/2022

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000